02 / the children grew faster despite a growth hormone shortage
Sermorelin helped child growth; adult aging benefits remain unproved
The child trial checked growth during sermorelin treatment for a hormone shortage. That wasn't a test of your sleep, recovery or health in old age.
Start here: a child study cannot prove better health in old age
Children lacking enough growth hormone grew faster while receiving sermorelin [12]. The trial wasn't testing sleep or recovery in older adults. Claims about adult health often draw on personal accounts, medical opinions or studies of another medicine. One published opinion said the evidence didn't justify medicines prompting the gland to release growth hormone as treatment for aging [10].
The benefit offered to you needs evidence from adults receiving sermorelin.
Sermorelin copies a natural hormone message's active portion. A small gland below the brain receives the copied message and releases extra growth hormone. A review explains the gland's response [8]. The liver also produces more of a protein needed for muscle and organ growth. The response explains the interest in treatment; the response doesn't prove an adult benefit.
The earlier U.S. approved use of sermorelin concerned childhood growth problems, and sales later ended for business reasons rather than safety concerns or failure of the medicine to work. Pharmacies now make a person's sermorelin prescription under pharmacy rules. That permission leaves adult aging without an approved use. I'd bring the benefit promised to your doctor. Which sermorelin trial supports that promise? Ask which country's approval rules apply.
Different changes make each peptide last for a different time
Sermorelin uses a shorter working portion of the body's natural hormone message. Changes in tesamorelin make breakdown slower. CJC-1295 has other changes that resist breakdown. Once in the blood, its long form joins a protein normally present there. Joining that protein makes the medicine last longer. The protein isn't added to the bottle: joining happens in blood, and that difference changes how long the gland is asked to release growth hormone after the medicine enters your body.
More time acting in your body isn't proof of more help.
Sermorelin had an earlier prescription approval that CJC-1295 didn't have, but that childhood trial can't establish your proposed adult benefit. Tesamorelin's findings can't prove sermorelin's benefits either. The medicines may prompt the same gland while producing different results or harms.
A review discusses these hormones and the medicines based on their messages [8]. A review brings earlier work together; the review isn't a new treatment trial. Your doctor needs findings about the named medicine and the actual improvement offered. Ask whether adults received sermorelin and whether researchers measured that change.
The gland can slow release; that brake does not prove adult benefit
Your body still has messages that slow release from the gland during sermorelin treatment. Direct replacement growth hormone skips that gland step. One doctor favored sermorelin partly because the body's brake remained [11]. The doctor was giving a published opinion, rather than reporting a treatment trial.
You'll need more than an explanation of hormone release to judge the promised help.
With sermorelin, the gland releases more growth hormone while continuing the bursts of release. A protein needed for muscle and organ growth is then produced in greater amounts by the liver. As the levels rise, messages from elsewhere in the body can slow release. A working brake still leaves benefits and harms to be tested.
A separate trial found better memory and thinking test scores in older adults. Some adults were healthy, while others had slight difficulty remembering or thinking clearly. Body fat decreased and the liver protein increased [9]. The medicine in that trial was tesamorelin; the adults weren't given sermorelin. At your visit, keep the tested medicine's name beside the finding. A tesamorelin result can't settle whether your memory or daily health would improve with sermorelin.
The sermorelin growth trial studied children before puberty
In their first year receiving sermorelin, children with a growth hormone shortage grew faster. Several medical centers took part. The children were still before puberty, the start of body changes toward adulthood. The authors found no excessive production of a liver protein used for growth [12]. The amount they judged excessive isn't given here. That statement doesn't establish a safe level for your own blood test.
Those children weren't tested for the adult benefits now being offered.
The trial didn't answer questions about adult sleep, recovery, fat loss or clearer thinking. A review describes the related hormones and their effects [8]. One doctor favored sermorelin for adults who begin making too little growth hormone [11]. A hormone shortage is a particular health problem, so that argument isn't proof of help with ordinary aging. Another doctor's opinion judged the evidence inadequate for aging treatment [10]. Neither opinion was a treatment test resolving those questions.
A different trial found better memory and thinking scores in older adults given tesamorelin [9]. The size of that improvement isn't supplied here. Your sermorelin discussion needs findings from adults actually receiving sermorelin for the help proposed.
People trying sermorelin describe sleep changes and unwanted effects
These descriptions are from users trying sermorelin for research themselves. The users weren't in a trial comparing treatment with no treatment. Whether sermorelin caused their reported changes hasn't been checked by a trial. Some people say they slept more deeply or had clearer dreams. Others mention easier recovery or more even daytime energy. Some describe gradual muscle or fat changes without clear measurements. The accounts haven't established how much treatment helps.
You can't estimate the chance of help or harm from these descriptions.
People also describe headaches, sore shot sites, dizziness, nausea and puffiness. Flushing means the skin suddenly feels hot and turns red. Reports mention appetite changes, feeling groggy, tingling hands and higher blood sugar. Food, sleep, exercise and expectations may affect what a person notices. You can't tell which change explains a personal experience from the report alone.
Tissue growth depends in part on growth hormone and the protein raised in the liver. Keeping levels high for years has unresolved risks. Insulin controls the sugar circulating in your blood. Growth hormone can work against insulin [8]. Include your medicine list and past illnesses when discussing those risks. A hormone response can't prove bottle contents or rule out unwanted ingredients. The evidence here lacks large trials following adults long enough to prove slower aging with sermorelin. A published opinion warned against treating aging routinely with these medicines [10]. The old childhood approval doesn't prove today's adult claims.
An old child approval is separate from your present prescription
Tesamorelin has a current approval for a different use. Sermorelin's earlier approval concerned children needing help with growth. CJC-1295 never gained that earlier prescription approval. A pharmacy's permission to make a person's medicine answers another question: whether that prescription may be prepared under the rules concerned.
Pharmacy permission doesn't establish a treatment that slows your aging.
Discuss the rules for your proposed prescription with a pharmacist. Ask what was once approved and whether that approval still applies. Then ask what checks the pharmacy makes today. Those are separate questions, and your adult benefit still needs evidence.
MOTS-c acts on energy use inside cells without prompting extra release from the gland. The comparison of studies sets out the different findings. Bring the exact medicine, intended use and country into your discussion. A child growth result doesn't establish healthier aging in an older person.